Because of the rarity of this observation, it is not clear whether the concomitant KRAS and BRAF mutant tumors have a different biology and natural history than singly KRAS or BRAF mutant tumors, or which of the two mutations play the dominant role in driving the tumor proliferation. The gene discussed is BRAF; the disease is neoplasm.